213 related articles for article (PubMed ID: 18157074)
21. Mechanisms of bone metastasis.
Roodman GD
N Engl J Med; 2004 Apr; 350(16):1655-64. PubMed ID: 15084698
[No Abstract] [Full Text] [Related]
22. Correlation between extent of osteolytic damage and metastatic burden of human breast cancer metastasis in nude mice: real-time PCR quantitation.
Tester AM; Sharp JA; Dhanesuan N; Waltham M; Thompson EW
Clin Exp Metastasis; 2002; 19(5):377-83. PubMed ID: 12198765
[TBL] [Abstract][Full Text] [Related]
23. Evaluating the effects of mixed osteolytic/osteoblastic metastasis on vertebral bone quality in a new rat model.
Wise-Milestone L; Akens MK; Rosol TJ; Hojjat SP; Grynpas MD; Whyne CM
J Orthop Res; 2012 May; 30(5):817-23. PubMed ID: 22025272
[TBL] [Abstract][Full Text] [Related]
24. Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis.
Mulholland BS; Forwood MR; Morrison NA
Curr Osteoporos Rep; 2019 Dec; 17(6):538-547. PubMed ID: 31713180
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms of breast cancer metastases to bone.
Guise TA; Kozlow WM; Heras-Herzig A; Padalecki SS; Yin JJ; Chirgwin JM
Clin Breast Cancer; 2005 Feb; 5 Suppl(2):S46-53. PubMed ID: 15807924
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of tumor metastasis to the bone: challenges and opportunities.
Reddi AH; Roodman D; Freeman C; Mohla S
J Bone Miner Res; 2003 Feb; 18(2):190-4. PubMed ID: 12568395
[TBL] [Abstract][Full Text] [Related]
27. Targeting factors involved in bone remodeling as treatment strategies in prostate cancer bone metastasis.
Vessella RL; Corey E
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6285s-6290s. PubMed ID: 17062715
[TBL] [Abstract][Full Text] [Related]
28. Skeletal metastases: decreasing tumor burden by targeting the bone microenvironment.
Chirgwin JM; Guise TA
J Cell Biochem; 2007 Dec; 102(6):1333-42. PubMed ID: 17907152
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
Feeley BT; Krenek L; Liu N; Hsu WK; Gamradt SC; Schwarz EM; Huard J; Lieberman JR
Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463
[TBL] [Abstract][Full Text] [Related]
30. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.
Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M
J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis.
Lynch CC
Bone; 2011 Jan; 48(1):44-53. PubMed ID: 20601294
[TBL] [Abstract][Full Text] [Related]
32. In vivo tibial compression decreases osteolysis and tumor formation in a human metastatic breast cancer model.
Lynch ME; Brooks D; Mohanan S; Lee MJ; Polamraju P; Dent K; Bonassar LJ; van der Meulen MC; Fischbach C
J Bone Miner Res; 2013 Nov; 28(11):2357-67. PubMed ID: 23649605
[TBL] [Abstract][Full Text] [Related]
33. Future treatment of bone metastases.
Lipton A
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6305s-6308s. PubMed ID: 17062719
[TBL] [Abstract][Full Text] [Related]
34. Examination of the mechanisms of osteolysis in patients with metastatic breast cancer.
Trinkaus M; Ooi WS; Amir E; Popovic S; Kalina M; Kahn H; Singh G; Gainford MC; Clemons M
Oncol Rep; 2009 May; 21(5):1153-9. PubMed ID: 19360288
[TBL] [Abstract][Full Text] [Related]
35. The development and function of the skeleton and bone metastases.
Rodan GA
Cancer; 2003 Feb; 97(3 Suppl):726-32. PubMed ID: 12548569
[TBL] [Abstract][Full Text] [Related]
36. The effects of RANK blockade and osteoclast depletion in a model of pure osteoblastic prostate cancer metastasis in bone.
Whang PG; Schwarz EM; Gamradt SC; Dougall WC; Lieberman JR
J Orthop Res; 2005 Nov; 23(6):1475-83. PubMed ID: 16005175
[TBL] [Abstract][Full Text] [Related]
37. Pathogenesis of osteoblastic bone metastases from prostate cancer.
Ibrahim T; Flamini E; Mercatali L; Sacanna E; Serra P; Amadori D
Cancer; 2010 Mar; 116(6):1406-18. PubMed ID: 20108337
[TBL] [Abstract][Full Text] [Related]
38. Osteolytic bone metastasis in breast cancer.
Yoneda T; Sasaki A; Mundy GR
Breast Cancer Res Treat; 1994; 32(1):73-84. PubMed ID: 7819589
[TBL] [Abstract][Full Text] [Related]
39. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss.
Kim KR; Kim HJ; Lee SK; Ma GT; Park KK; Chung WY
PLoS One; 2015; 10(4):e0122764. PubMed ID: 25859665
[TBL] [Abstract][Full Text] [Related]
40. Differences of osteoblastic bone metastases and osteolytic bone metastases in clinical features and molecular characteristics.
Fang J; Xu Q
Clin Transl Oncol; 2015 Mar; 17(3):173-9. PubMed ID: 25351174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
